| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |